OncoMatch/Clinical Trials/NCT07689331
Hungarian National Systemic Amyloidosis Registry
Is NCT07689331 recruiting? Yes, currently enrolling (Jul 2026).
This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.
Check if I qualifyExtracted eligibility criteria
Cancer type
Multiple Myeloma
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07689331 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages